In support of this, S100A2 transcription repression in breast, lung, and prostate cancer cells and cell lines was shown to be mediated at least in part by site-specific methylation in the promoter region, similarly to a number of known and putative tumor suppressor genes [7, 9]. The gene discussed is S100A2; the disease is Familial prostate cancer.